Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.38), $0.02 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $6.84 million versus the consensus estimate of $15.75 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.